Priority topics

This page contains the priority topics for the ERS International Congress 2022, taking place in Barcelona, Spain from 4–6 September.

Check the session types web page for details on what is included in the congress programme.

Priority topics for 2022

The ERS International Congress 2022 programme will extensively cover the latest advances in research and clinical practice from the following topics and professional specialities:

Respiratory clinical care and physiology

Areas covered will include:

  • Long COVID, post ICU syndrome and rehabilitation.
  • Patients with overlapping lung diseases: clinical management and challenges.
  • Lung function testing during the COVID-19 pandemic and beyond.
  • Holistic management and rehabilitation of fibrosing interstitial lung diseases.
  • Maintenance of pulmonary rehabilitation benefits and role of digital health.

Respiratory intensive care

Areas covered will include:

  • Weaning from mechanical ventilation: lessons from WEAN-SAFE.
  • ERS Statement on dyspnea in acutely ill mechanically ventilated patients.
  • Lung ultrasound in acute respiratory care.
  • Advanced care planning in long-term mechanical ventilation.
  • Setting up chronic ventilation: what are the needs for different diseases?

Basic and translational sciences

Areas covered will include:

  • Lung tissue regeneration and repair.
  • Cell death modalities in chronic lung diseases affecting inflammation, autophagy, fibrosis and senescence.
  • Fundamentals of alveolar cell function.
  • Exposure-driven damage of the lung, including: microplastics, diesel exhaust, biomass fuels, e-cigarettes, climate change.
  • Effects of long COVID and fatigue on lung biology.

Sleep disordered breathing

Areas covered will include:

  • Myth or reality: is obstructive sleep apnoea really critical for cardiovascular complications? Does PAP treatment improve cardiovascular outcome? Limitations and strengths of large-sized trials, what is needed for the future.
  • New technologies in Sleep-disordered breathing diagnosis: one metric doesn’t fit all. Polysomnography, polygraphy (Typ-III devices), non-classical sensors: which parameters really matter? How can we diagnose more focused to the patient’ requirements?
  • The multi-components of obstructive sleep apnoea pathophysiology: from mechanics to hypoxic burden and intracellular mechanisms.
  • Residual daytime sleepiness: systematic analysis, treatment algorithm and the role of pharmaceutical agents.
  • More than obstructive sleep apnoea and central sleep apnoea: hypoventilation syndromes from identification to treatment and follow-up.

Airway diseases, asthma, COPD and chronic cough

Areas covered will include:

  • What is around the corner? New drugs in airways disease.
  • Precision medicine approaches in airway disease.
  • Updates in asthma management and treatment.
  • Updates on new biomarkers in airway disease.
  • Updates in the management and treatment of COPD.

Epidemiology and environment

Areas covered will include:

  • Respiratory health effects of low air pollution exposures.
  • Epidemiology as a digital tool for the improvement of public health.
  • Respiratory epidemiology from distribution, patterns and determinants of respiratory diseases to evidence-based practice.
  • Greenness, blueness and respiratory health.
  • Digital tools for improving asthma control across disease severity.


Areas covered will include:

  • Asthma: advances in diagnosis and management of acute asthma attacks, novel approaches to improve adherence in asthma.
  • Severe asthma in children.
  • Impact of COVID-19 in children with respiratory diseases.
  • Microbial manipulation in the treatment and prevention of asthma.
  • Phenotypes of bronchopulmonary dysplasia.

Thoracic surgery and transplantation

Areas covered will include:

  • Lung transplantation in patients not recovering from ARDS (including COVID-19): ethics, indications, pitfalls and outcomes.
  • Ground glass opacities after COVID pandemic: a new challenge for the thoracic oncology multidisciplinary team management.
  • Current treatment options in CVD-ILD: from immunosuppression to anti-fibrotics and transplantation.
  • Is surgery for stage IV-M1a lung cancer justified?
  • Integrating artificial intelligence and innovative techniques in the management of chest malignancies.

Allied respiratory professionals

Areas covered will include:

  • Assessment of respiratory function using digitised technology.
  • Utilising exercise testing in pre-operative assessment, rehabilitation and exercise prescription.

Respiratory infections

Areas covered will include:

  • New antimicrobial strategy.
  • Transmission of respiratory infections. Should we rethink mass gatherings?
  • Respiratory infections in healthcare settings. What have we learned? Are we prepared?
  • Respiratory infection in the immunocompromised host: from prevention to diagnosis and treatment
  • Promises and advances in tuberculosis diagnostic, treatment and prevention (UNITE4TB).

Thoracic oncology

Areas covered will include:

  • Lung cancer screening: update 2022.
  • Multidisciplinary team management in thoracic oncology V4.0.
  • Multidisciplinary care of stage III non-small-cell lung carcinoma.
  • Diagnostic-therapeutic sequences in lung cancer.
  • Differential diagnoses/management of pulmonary nodules.

Interstitial lung diseases

Areas covered will include:

  • Connective tissue diseases and the lung.
  • Novel insights into the diagnosis of fibrosis.
  • Idiopathic pulmonary fibrosis: from bench to bedside.
  • Fibrosis and lung cancer.
  • Pulmonary hypertension in fibrotic lung diseases; to treat or not to treat.

Pulmonary vascular diseases

Areas covered will include:

  • Novel treatment targets in pulmonary arterial hypertension.
  • From chronic thromboembolic disease to chronic thromboembolic pulmonary hypertension: diagnosing and treating symptoms after acute pulmonary embolism.
  • The hemodynamic definition of pulmonary hypertension at rest and exercise.
  • Novel imaging techniques in pulmonary hypertension.
  • Understanding low diffusion capacity in pulmonary arterial hypertension.

Clinical techniques, imaging and endoscopy

Areas covered will include:

  • Interventional pulmonology.
  • Interventional pulmonology workstations.
  • Transbronchial (cryo)biopsy and surgical lung biopsy in interstitial lung diseases.
  • Ultrasound.
  • Endobronchial ultrasound (EBUS)/ Esophageal ultrasound with ultrasound bronchoscope (EUS-B).

The ERS Congress Programme Committee encourages you to develop sessions that include faculty members of varying ages, backgrounds, specialities and gender. The congress theme should be reflected in session proposals as much as possible.

Topics last updated in June 2021.

Contact us

Do you have questions about the congress programme or session proposals?

Get in touch